Electronic Source Data in Clinical Investigations: Navigating the Final FDA Guidance October 2019

Oct 21, 2019
Order the recording of this seminar

Course Description

As the use of electronic source documentation (eSource) increases, so does the scrutiny for ensuring the integrity of the systems used to generate and retain electronic source data. In late 2010, the FDA issued a draft guidance regarding the use of eSource, providing direction on capturing, using, and archiving electronic data. A final FDA guidance was released in September 2013 focusing on identification and specification of authorized source data originators, the creation of data element identifiers to facilitate examination of the data audit trail, capture of source data into the eCRF, and Investigator responsibilities. This web seminar will review how the requirements for paper source documentation translate to the electronic source document as well as examine real-world examples of the FDA’s review of eSource.

Video Preview

Learning Objectives

  • Navigate initiatives in the regulatory climate leading to the eSource guidance
  • Examine the three tiers of data management
  • Discuss the Clinical Investigator’s responsibilities for eSource data origination, integrity, review, release for processing and retention
  • Assess the implications of the guidance on source documentation practices and policy
  • Review the FDA’s expectations and inspection processes for eSource

Who Should Attend

  • Clinical Research Associates and Managers
  • Project Managers
  • Clinical Investigators and Staff
  • Personnel involved in site and IRB assessment and/or selection
  • Academia Professionals involved in oversight, documentation, and conduct of clinical research
  • Quality Assurance and Compliance Professionals
  • Data Management Professionals


Elizabeth Ronk Nelson, M.P.H.

Click here for complete trainer biographies


Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.